Lisata Therapeutics, Inc.
US ˙ NasdaqCM ˙ US1280583022

Introduction

This page provides a comprehensive analysis of the known insider trading history of Steven M Klosk. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Steven M Klosk has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:LSTA / Lisata Therapeutics, Inc. Director 65,359
Director 72,500
US:CBM / Cambrex Corp. President & CEO, Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Steven M Klosk. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases LSTA / Lisata Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in LSTA / Lisata Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2014-11-25 NBS KLOSK STEVEN M 10,000 3.9850 10,000 3.9850 39,850 731

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LSTA / Lisata Therapeutics, Inc. Insider Trades
Insider Sales LSTA / Lisata Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in LSTA / Lisata Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LSTA / Lisata Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Steven M Klosk as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-01-13 2025-01-09 4 LSTA LISATA THERAPEUTICS, INC.
Common Stock
A - Award 15,789 65,359 31.85
2024-11-27 2024-11-25 4 BSLK Bolt Projects Holdings, Inc.
Common Stock
A - Award 15,000 72,500 26.09
2024-11-27 2024-11-25 4 BSLK Bolt Projects Holdings, Inc.
Common Stock
A - Award 22,500 57,500 64.29
2024-08-15 2024-08-13 4 BSLK Bolt Projects Holdings, Inc.
Common Stock
M - Exercise 35,000 35,000
2024-01-11 2024-01-09 4 LSTA LISATA THERAPEUTICS, INC.
Common Stock
A - Award 19,480 49,570 64.74
2023-01-11 2023-01-09 4 LSTA LISATA THERAPEUTICS, INC.
Common Stock
A - Award 20,000 30,090 198.22
2022-01-12 2022-01-10 4 CLBS CALADRIUS BIOSCIENCES, INC.
Common Stock
A - Award 65,430 151,390 76.12
2021-01-12 2021-01-11 4 CLBS CALADRIUS BIOSCIENCES, INC.
Common Stock
A - Award 37,735 85,960 78.25
2020-01-14 2020-01-13 4 CLBS CALADRIUS BIOSCIENCES, INC.
Restricted Stock Units
A - Award 18,292 48,225 61.11 3.28 59,998 158,178
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 30,000 0 -100.00
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 38,000 0 -100.00
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 50,000 0 -100.00
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 50,000 0 -100.00
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Common Stock
S - Sale -347,206 0 -100.00 60.00 -20,832,360
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Common Stock
A - Award 65,500 347,206 23.25
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Common Stock
M - Exercise 30,000 281,706 11.92 53.60 1,608,150 15,100,850
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Common Stock
M - Exercise 38,000 251,706 17.78 45.64 1,734,320 11,487,862
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Common Stock
M - Exercise 50,000 213,706 30.54 40.65 2,032,500 8,687,149
2019-12-05 2019-12-04 4 CBM CAMBREX CORP
Common Stock
M - Exercise 50,000 163,706 43.97 41.36 2,068,000 6,770,880
2019-02-19 2019-02-15 4 CBM CAMBREX CORP
Common Stock
A - Award 20,000 113,706 21.34
2019-02-04 2019-01-31 4 CBM CAMBREX CORP
Common Stock
A - Award 10,378 93,706 12.45
2019-01-16 2019-01-14 4 CLBS CALADRIUS BIOSCIENCES, INC.
Restricted Stock Units
A - Award 12,121 29,933 68.05 4.95 59,999 148,168
2019-01-10 2019-01-08 4 CLBS CALADRIUS BIOSCIENCES, INC.
Common Stock
A - Award 8,747 17,812 96.49
2018-10-26 2018-10-24 4 CBM CAMBREX CORP
Stock Option (right to buy)
A - Award 30,000 30,000
2018-10-24 2018-10-23 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 20,000 0 -100.00
2018-10-24 2018-10-23 4 CBM CAMBREX CORP
Common Stock
S - Sale X -3,195 83,328 -3.69 55.27 -176,593 4,605,689
2018-10-24 2018-10-23 4 CBM CAMBREX CORP
Common Stock
S - Sale X -16,805 86,523 -16.26 54.67 -918,660 4,729,858
2018-10-24 2018-10-23 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 20,000 103,328 24.00 17.81 356,200 1,840,272
2018-09-05 2018-09-04 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 55,000 20,000 -157.14
2018-09-05 2018-09-04 4 CBM CAMBREX CORP
Common Stock
S - Sale X -25,809 83,328 -23.65 66.83 -1,724,815 5,568,810
2018-09-05 2018-09-04 4 CBM CAMBREX CORP
Common Stock
S - Sale X -29,191 109,137 -21.10 65.84 -1,921,935 7,185,580
2018-09-05 2018-09-04 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 55,000 138,328 66.00 17.81 979,550 2,463,622
2018-08-07 2018-08-06 4 CBM CAMBREX CORP
Common Stock
S - Sale -26,401 83,328 -24.06 63.23 -1,669,335 5,268,829
2018-08-07 2018-08-06 4 CBM CAMBREX CORP
Common Stock
S - Sale -53,599 109,729 -32.82 62.07 -3,326,890 6,810,879
2018-08-07 2018-05-07 4 CBM CAMBREX CORP
Common Stock
A - Award 80,000 163,328 96.01
2018-08-02 2018-08-01 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 5,000 75,000 7.14
2018-08-02 2018-08-01 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 50,000 0 -100.00
2018-08-02 2018-08-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -22,782 163,328 -12.24 62.78 -1,430,222 10,253,503
2018-08-02 2018-08-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -32,218 186,110 -14.76 62.23 -2,005,026 11,582,202
2018-08-02 2018-08-01 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 5,000 218,328 2.34 17.81 89,050 3,888,422
2018-08-02 2018-08-01 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 50,000 213,328 30.61 16.90 845,250 3,606,310
2018-07-03 2018-07-02 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 30,000 50,000 150.00
2018-07-03 2018-07-02 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 25,000 0 -100.00
2018-07-03 2018-07-02 4 CBM CAMBREX CORP
Common Stock
S - Sale X -24,358 163,328 -12.98 52.08 -1,268,565 8,506,122
2018-07-03 2018-07-02 4 CBM CAMBREX CORP
Common Stock
S - Sale X -30,642 187,686 -14.03 51.45 -1,576,531 9,656,445
2018-07-03 2018-07-02 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 30,000 218,328 15.93 16.90 507,150 3,690,835
2018-07-03 2018-07-02 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 25,000 188,328 15.31 12.46 311,500 2,346,567
2018-06-12 2018-06-11 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 55,000 25,000 -183.33
2018-06-12 2018-06-11 4 CBM CAMBREX CORP
Common Stock
S - Sale X -55,000 163,328 -25.19 45.64 -2,510,244 7,454,421
2018-06-12 2018-06-11 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 55,000 218,328 33.67 12.46 685,300 2,720,367
2018-01-10 2018-01-08 4 CLBS CALADRIUS BIOSCIENCES, INC.
Restricted Stock Units
A - Award 8,747 8,747
2017-11-01 2017-10-30 4 CBM CAMBREX CORP
Stock Option (right to buy)
A - Award 38,000 38,000
2017-10-03 2017-10-02 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 4,000 0 -100.00
2017-10-03 2017-10-02 4 CBM CAMBREX CORP
Common Stock
S - Sale X -4,000 83,328 -4.58 54.96 -219,830 4,579,507
2017-10-03 2017-10-02 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 4,000 87,328 4.80 5.72 22,880 499,516
2017-09-05 2017-09-01 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 12,000 4,000 -150.00
2017-09-05 2017-09-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -1,298 83,328 -1.53 52.08 -67,600 4,339,739
2017-09-05 2017-09-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -10,702 84,626 -11.23 51.47 -550,787 4,355,345
2017-09-05 2017-09-01 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 12,000 95,328 14.40 5.72 68,640 545,276
2017-08-02 2017-08-01 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 12,000 16,000 300.00
2017-08-02 2017-08-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -6,439 83,328 -7.17 61.65 -396,964 5,137,171
2017-08-02 2017-08-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -5,561 89,767 -5.83 61.09 -339,705 5,483,606
2017-08-02 2017-08-01 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 12,000 95,328 14.40 5.72 68,640 545,276
2017-07-05 2017-07-03 4 CBM CAMBREX CORP
Stock Option ( right to buy)
M - Exercise 12,000 28,000 75.00
2017-07-05 2017-07-03 4 CBM CAMBREX CORP
Common Stock
S - Sale X -12,000 83,328 -12.59 59.66 -715,907 4,971,257
2017-07-05 2017-07-03 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 12,000 95,328 14.40 5.72 68,640 545,276
2017-06-02 2017-06-01 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 12,000 40,000 42.86
2017-06-02 2017-06-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -6,200 83,328 -6.93 54.65 -338,824 4,553,800
2017-06-02 2017-06-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -5,800 89,528 -6.08 53.69 -311,406 4,806,821
2017-06-02 2017-06-01 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 12,000 95,328 14.40 5.72 68,640 545,276
2017-05-18 2017-05-16 4 CLBS Caladrius Biosciences, Inc.
Common Stock
A - Award 2,565 9,065 39.46
2017-05-02 2017-05-01 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 12,000 52,000 30.00
2017-05-02 2017-05-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -300 83,328 -0.36 59.72 -17,915 4,976,073
2017-05-02 2017-05-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -1,000 83,628 -1.18 58.86 -58,858 4,922,135
2017-05-02 2017-05-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -10,700 84,628 -11.22 58.09 -621,573 4,916,117
2017-05-02 2017-05-01 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 12,000 95,328 14.40 5.72 68,640 545,276
2017-04-03 2017-04-03 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 12,000 64,000 23.08
2017-04-03 2017-04-03 4 CBM CAMBREX CORP
Common Stock
S - Sale X -12,000 83,328 -12.59 54.58 -654,960 4,548,042
2017-04-03 2017-04-03 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 12,000 95,328 14.40 5.72 68,640 545,276
2017-03-02 2017-03-01 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 12,000 76,000 18.75
2017-03-02 2017-03-01 4 CBM CAMBREX CORP
Common Stock
S - Sale X -12,000 83,328 -12.59 56.70 -680,444 4,725,006
2017-03-02 2017-03-01 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 12,000 95,328 14.40 5.72 68,640 545,276
2017-02-17 2017-02-16 4 CBM CAMBREX CORP
Common Stock
S - Sale -4,326 83,328 -4.94 53.10 -229,711 4,424,717
2017-02-17 2017-02-09 4 CBM CAMBREX CORP
CommonStock
S - Sale -2,191 92,050 -2.32 52.30 -114,589 4,814,215
2017-02-17 2017-02-09 4 CBM CAMBREX CORP
Common Stock
S - Sale -12,909 94,241 -12.05 52.25 -674,495 4,924,092
2017-02-17 2015-02-15 4 CBM CAMBREX CORP
Common Stock
S - Sale -4,396 87,654 -4.78 52.75 -231,889 4,623,748
2017-02-14 2017-02-13 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 12,000 88,000 15.79
2017-02-14 2017-02-13 4 CBM CAMBREX CORP
Common Stock
S - Sale X -100 107,150 -0.09 52.75 -5,275 5,652,162
2017-02-14 2017-02-13 4 CBM CAMBREX CORP
Common Stock
S - Sale X -11,900 107,250 -9.99 52.09 -619,859 5,586,545
2017-02-14 2017-02-13 4 CBM CAMBREX CORP
Common Stock
M - Exercise X 12,000 119,150 11.20 5.72 68,640 681,538
2017-02-14 2017-02-10 4 CBM CAMBREX CORP
Common Stock
S - Sale -1,912 107,150 -1.75 53.36 -102,015 5,716,988
2017-02-14 2017-02-10 4 CBM CAMBREX CORP
Common Stock
S - Sale -49,266 109,062 -31.12 52.62 -2,592,574 5,739,279
2017-02-08 2017-02-07 4 CBM CAMBREX CORP
Common Stock
A - Award 80,000 163,328 96.01
2017-02-08 2007-02-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -5,000 158,328 -3.06 55.00 -275,000 8,708,040
2017-01-31 2017-01-09 4 CLBS Caladrius Biosciences, Inc.
Options to Purchase Common Stock
A - Award 2,750 2,750
2017-01-31 2017-01-09 4 CLBS Caladrius Biosciences, Inc.
Common Stock
A - Award 1,650 6,500 34.02
2016-11-14 2016-11-09 4 CBM CAMBREX CORP
Common Stock
S - Sale -50,000 83,328 -37.50 50.87 -2,543,500 4,238,895
2016-10-28 2016-10-26 4 CBM CAMBREX CORP
Stock Option (right to buy)
A - Award -50,000 50,000 -50.00
2016-06-23 2016-06-22 4 CLBS Caladrius Biosciences, Inc.
Options to Purchase Common Stock
A - Award 12,500 12,500
2016-06-23 2016-06-22 4 CLBS Caladrius Biosciences, Inc.
Common Stock
A - Award 7,500 48,500 18.29
2016-05-10 2016-05-09 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 14,005 0 -100.00
2016-05-10 2016-05-09 4 CBM CAMBREX CORP
Common Stock
S - Sale -14,005 133,328 -9.51 49.00 -686,245 6,533,072
2016-05-10 2016-05-09 4 CBM CAMBREX CORP
Common Stock
M - Exercise 14,005 147,333 10.50 4.38 61,342 645,319
2016-05-05 2016-05-05 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 12,930 14,005 1,202.79
2016-05-05 2016-05-05 4 CBM CAMBREX CORP
Common Stock
S - Sale -12,930 133,328 -8.84 49.03 -633,958 6,537,072
2016-05-05 2016-05-05 4 CBM CAMBREX CORP
Common Stock
M - Exercise 12,930 146,258 9.70 4.38 56,633 640,610
2016-05-05 2016-05-03 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 3,500 26,935 14.93
2016-05-05 2016-05-03 4 CBM CAMBREX CORP
Common Stock
S - Sale -3,500 133,328 -2.56 49.51 -173,285 6,601,069
2016-05-05 2016-05-03 4 CBM CAMBREX CORP
Common Stock
M - Exercise 3,500 136,828 2.63 4.38 15,330 599,307
2016-03-17 2016-03-16 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 19,565 30,435 179.99
2016-03-17 2016-03-16 4 CBM CAMBREX CORP
Common Stock
S - Sale -19,565 133,328 -12.80 41.00 -802,165 5,466,448
2016-03-17 2016-03-16 4 CBM CAMBREX CORP
Common Stock
M - Exercise 19,565 152,893 14.67 4.38 85,695 669,671
2016-02-12 2016-02-11 4 CBM CAMBREX CORP
Common Stock
S - Sale -39,542 133,328 -22.87 36.20 -1,431,420 4,826,474
2016-02-12 2016-02-11 4 CBM CAMBREX CORP
Common Stock
A - Award 72,000 172,870 71.38
2016-01-27 2016-01-25 4 CLBS Caladrius Biosciences, Inc.
Options to Purchase Common Stock
A - Award 15,000 15,000
2016-01-27 2016-01-25 4 CLBS Caladrius Biosciences, Inc.
Common Stock
A - Award 9,000 41,000 28.12
2015-11-09 2015-11-05 4 CBM CAMBREX CORP
Phantom Stock Units
M - Exercise -49,121 0 -100.00
2015-11-09 2015-11-05 4 CBM CAMBREX CORP
Common Stock
S - Sale -10,800 100,870 -9.67 51.31 -554,148 5,175,640
2015-11-09 2015-11-05 4 CBM CAMBREX CORP
Common Stock
S - Sale -38,321 111,670 -25.55 50.57 -1,937,893 5,647,152
2015-11-09 2015-11-05 4 CBM CAMBREX CORP
Common Stock
M - Exercise 49,121 149,991 48.70
2015-10-27 2015-10-21 4 CBM CAMBREX CORP
Stock Option (Right to buy)
A - Award 50,000 50,000
2015-08-05 2015-08-04 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 58,980 50,000 -656.79
2015-08-05 2015-08-04 4 CBM CAMBREX CORP
Common Stock
S - Sale -58,980 100,870 -36.90 50.07 -2,953,129 5,050,561
2015-08-05 2015-08-04 4 CBM CAMBREX CORP
Common Stock
M - Exercise 58,980 159,850 58.47 4.38 258,332 700,143
2015-08-05 2015-08-03 4 CBM CAMBREX CORP
Stock Option (right to buy)
M - Exercise 41,020 108,980 60.36
2015-08-05 2015-08-03 4 CBM CAMBREX CORP
Common Stock
S - Sale -41,020 100,870 -28.91 50.00 -2,051,000 5,043,500
2015-08-05 2015-08-03 4 CBM CAMBREX CORP
Common Stock
M - Exercise 41,020 141,890 40.67 4.38 179,668 621,478
2015-06-04 2015-06-02 4 NBS NeoStem, Inc.
Common Stock, $0.001 par value
A - Award 10,000 32,000 45.45
2015-02-11 2015-02-10 4 CBM CAMBREX CORP
Common Stock
S - Sale -45,000 100,870 -30.85 30.32 -1,364,270 3,058,086
2015-01-02 2015-01-02 4 NBS NeoStem, Inc.
Common Stock, $0.001 par value
A - Award 12,000 22,000 120.00
2014-11-25 2014-11-25 4 NBS NeoStem, Inc.
Common Stock, $0.001 par value
P - Purchase 10,000 10,000 3.98 39,850 39,850
2014-10-23 2014-10-22 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
M - Exercise 80,000 80,000
2014-09-04 2014-09-03 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
M - Exercise -66,257 0 -100.00
2014-09-04 2014-09-03 4 CBM CAMBREX CORP
Common Stock
S - Sale -66,257 145,870 -31.23 22.02 -1,458,688 3,211,416
2014-09-04 2014-09-03 4 CBM CAMBREX CORP
Common Stock
M - Exercise 66,257 212,127 45.42 5.60 371,370 1,188,972
2014-09-04 2014-09-02 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
M - Exercise -60,000 66,257 -47.52
2014-09-04 2014-09-02 4 CBM CAMBREX CORP
Common Stock
S - Sale -60,000 145,870 -29.14 22.01 -1,320,750 3,210,963
2014-09-04 2014-09-02 4 CBM CAMBREX CORP
Common Stock
M - Exercise 60,000 205,870 41.13 5.60 336,300 1,153,901
2014-08-21 2014-08-19 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
M - Exercise -4,702 126,257 -3.59
2014-08-21 2014-08-19 4 CBM CAMBREX CORP
Common Stock
S - Sale -4,702 145,870 -3.12 22.00 -103,450 3,209,315
2014-08-21 2014-08-19 4 CBM CAMBREX CORP
Common Stock
M - Exercise 4,702 150,572 3.22 5.60 26,355 843,956
2014-08-08 2014-08-07 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
M - Exercise -1,200 130,959 -0.91
2014-08-08 2014-08-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -1,200 145,870 -0.82 22.52 -27,022 3,284,715
2014-08-08 2014-08-07 4 CBM CAMBREX CORP
Common Stock
M - Exercise 1,200 147,070 0.82 5.60 6,726 824,327
2014-07-09 2014-07-08 4 NBS NeoStem, Inc.
Stock Option (right to purchase)
A - Award 18,700 18,700
2014-02-18 2014-02-13 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
M - Exercise -10,000 0 -100.00
2014-02-18 2014-02-13 4 CBM CAMBREX CORP
Common Stock
S - Sale -10,000 145,870 -6.42 19.75 -197,500 2,880,932
2014-02-18 2014-02-13 4 CBM CAMBREX CORP
Common Stock
M - Exercise 10,000 155,870 6.86 13.75 137,500 2,143,212
2013-11-22 2013-11-20 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
M - Exercise -17,841 132,159 -11.89
2013-11-22 2013-11-20 4 CBM CAMBREX CORP
Common Stock
M - Exercise 17,841 162,712 12.32 5.60 99,999 912,001
2013-10-30 2013-10-28 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
A - Award 80,000 80,000
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Stock Option (Right to Buy)
M - Exercise -8,500 0 -100.00
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -2,149 144,871 -1.46 12.45 -26,755 1,803,644
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -1,000 147,020 -0.68 12.45 -12,454 1,831,061
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -1,135 148,020 -0.76 12.46 -14,142 1,844,329
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -333 149,155 -0.22 12.47 -4,153 1,859,963
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -400 149,488 -0.27 12.49 -4,996 1,867,105
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -2,100 149,888 -1.38 12.50 -26,250 1,873,600
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -700 151,988 -0.46 12.52 -8,764 1,902,890
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -200 152,688 -0.13 12.53 -2,506 1,913,181
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
S - Sale -483 152,888 -0.31 12.55 -6,062 1,918,744
2013-05-08 2013-05-07 4 CBM CAMBREX CORP
Common Stock
M - Exercise 8,500 153,371 5.87 7.39 62,815 1,133,412
2012-10-26 2012-10-24 4 CBM CAMBREX CORP
Stock Option (Right to Bujy)
A - Award 80,000 80,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)